HOME >> BIOLOGY >> NEWS
A friendly foe -- Bacteria residing in the gut boost immune response to tumors

One potent, immune-based treatment for cancer is total body irradiation (TBI). This approach first depletes the body of the population of immune cells known as lymphocytes and then involves the adoptive transfer of tumor-specific T cells to the patient. Lymphodepletion has previously been shown to improve the ability of tumor-specific T cells to cause tumor regression. In a study appearing online on July 26 in advance of publication in the August print issue of the Journal of Clinical Investigation, Nicholas Restifo and colleagues from the National Cancer Institute show that, in mice, lymphodepletion does not fully account for the tumor regression observed following TBI. They show that a disruption of the population of bacteria that normally reside in the gut without causing disease also plays a role in the effectiveness of this therapeutic approach for cancer.

A specific population of bacteria present in our gut is crucial to our health. However, some treatments for cancer, particularly those that deplete the bodys immune cells, have high potential to disrupt the natural balance between our bodies and these commensal microorganisms, causing disease. Restifo and colleagues subjected mice genetically deficient in lymphocytes to TBI and found that, like TBI-treated mice with intact lymphocytes, TBI was still able to positively augment the function of adoptively transferred tumor-specific CD8+ T cells and cause tumor regression. This surprising result indicated that another mechanism for the efficacy of TBI also exists. They found that in these mutant, irradiated mice the lining of their gut was injured, allowing the passage of commensal bacteria from the gut to the lymph nodes, where the immune response to their presence increased the activation of tumor-specific CD8+ T cells and resulted in tumor regression. This effect was found to involve toll-like receptor 4. Conversely, a reduction in the number of host microorganisms by the use of antibiotics reduce
'"/>

Contact: Brooke Grindlinger
press_releases@the-jci.org
734-546-5242
Journal of Clinical Investigation
26-Jul-2007


Page: 1 2

Related biology news :

1. FSU pushing boundaries with environmentally friendly community
2. New Queens study offers environmentally friendly solution to oil industry needs
3. Eco-friendly bug sucker
4. Research shows Europeans prefer environmentally-friendly seafood
5. Switchable solvents make chemical manufacturing more environmentally-friendly
6. Chemical Society announces EPA awards for environmentally friendly technologies
7. Plant pathologists evaluate eco-friendly alternatives to methyl bromide
8. Fungus-friendly scientists meet in Tucson
9. Bacteria may not hasten death
10. Bacteria ferry nanoparticles into cells for early diagnosis, treatment
11. Bacteria show promise in fending off global amphibian killer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/1/2018)... ... August 01, 2018 , ... Clinical Training for Regenerative Medicine ... staff. , This full day course is an interactive day with lectures, demonstrations, ... staff to regenerative medicine procedures and processing techniques, and facility providing them with ...
(Date:7/31/2018)... ... ... Fiberstar, Inc. , a global leader of clean label, functional fibers ... Fiberstar added capacity, introduced new Citri-Fi® products and entered into new categories. To increase ... with Batory Foods. , “Batory Foods has an excellent track record within the ...
(Date:7/27/2018)... ... July 27, 2018 , ... ... and representatives of the Biotechnology Innovation Organization (BIO) met with U.S. Environmental ... “Proposal for a Toxic Substances Control Act (TSCA) Inventory Representation and Equivalency ...
Breaking Biology News(10 mins):
(Date:8/7/2018)... ... August 06, 2018 , ... Slone Partners, ... the placement of Dr. Paul Harney as President, North America at Prescient Healthcare ... and enhancing client satisfaction. He was also named to Prescient’s Board of Directors. ...
(Date:7/31/2018)... Calif. (PRWEB) , ... July 31, 2018 , ... ... issued a major patent that covers methods for extracting and using adipose tissue-derived ... in any mammal, including humans. While this patent covers Canada specifically, VetStem ...
(Date:7/27/2018)... WASHINGTON (PRWEB) , ... July ... ... Biobased and Renewable Products Advocacy Group (BRAG®) and representatives of the Biotechnology ... discuss the two groups’ recently-issued white paper, “Proposal for a Toxic Substances ...
(Date:7/25/2018)... ... July 25, 2018 , ... Dimitrius ... proprietary nutraceutical to combat inflammation and autoimmune disorders. , The preclinical research ... The following data was reported:, Over 70% decrease ...
Breaking Biology Technology:
Cached News: